Pflanzenextrakte mit Antidiabetischer Wirkung und Anderen Nützlichen Wirkungen

EP4772250 8. Juli 2026

Anmelder: Housey Pharmaceutical Research Laboratories, L.L.C. 🇺🇸

Details

Veröffentlichungs-Nr.
EP4772250
Anmeldetag
11. Mai 2018
Veröffentlichung
8. Juli 2026
Rechtsraum
EP
IPC
A61Q19/00
Offizieller Volltext

Abstract

This invention relates to plant extracts containing nutritionally beneficial or medicinally active compounds. Some of these extracts, or the purified compounds contained therein, may be used for the nutritional support, prevention, treatment, or possible cure of various metabolic and other diseases and disorders in human beings and animals, including type 1 and type 2 diabetes, by regulating insulin signaling. This regulatory effect may include modulations of the levels and/or activity of the Insulin Receptor (IR), the Insulin-like Growth Factor (IGF) Receptor, and/or the Insulin Receptor Substrate (IRS) proteins in cells and tissues in the body.

Anmelder

Firma
Housey Pharmaceutical Research Laboratories, L.L.C.
Land
🇺🇸 USA

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen